jensmithmi Profile Banner
Jen Smith Profile
Jen Smith

@jensmithmi

Followers
434
Following
725
Media
286
Statuses
3K

Pharmacist. All opinions are mine, mine, MINE!

Birmingham, England
Joined August 2016
Don't wanna be here? Send us removal request.
@jensmithmi
Jen Smith
4 years
Want to know how to use Ovid to search Medline & Embase, then combine and de-duplicate results? Here's a video: https://t.co/DS3rkfsvrR #CPD #LiteratureSearching #MedicinesInformation #pharmacy
1
2
6
@bmj_latest
The BMJ
16 days
Interpreting liver blood test results can be challenging. How should clinicians interpret abnormal test results? New Education article offers guidance and a visual summary #BMJInfographic 🔗 https://t.co/QLrTJlDI1H
3
150
457
@ScholarshipfPhd
Scholarship for PhD
21 days
"Statistics for Non-Statisticians" by Birger Stjernholm Madsen (Springer, 2nd Edition) The book title every PhD student wishes they'd found in Year 1. If you're a researcher who needs to understand statistics without becoming a statistician, this is your roadmap. What makes it
8
97
421
@whitfieldlewis6
Whitfield Lewis, MD 🇦🇬🇺🇸
23 days
A young doctor asked me, “Why keep reading basic science?” Well, where to start? You never want to reduce your practice to robotically following algorithms and protocols — though those checks and balances have their place in patient care. As a neurologist, I don’t see reading
22
81
400
@PythonPr
Python Programming
25 days
Curve - Fitting Methods and the Messages They Send
2
103
564
@StefanFSchubert
Stefan Schubert
1 month
Study of AI sycophancy finds that DeepSeek and Llama models are among the most sycophantic and Gemini, Mistral, and Claude are among the least sycophantic (though still high relative to humans). "Overall, deployed LLMs overwhelmingly affirm user actions."
10
11
66
@jensmithmi
Jen Smith
1 month
A letter in the @PJOnline_News notes the risk of mis-selection now that there are two posaconazole suspension: 30mg/mL gastro-resistant and 40mg/mL plain. What is worse is that there are generics of 40mg/mL, so risk is unlikely to be short-term. https://t.co/qyav0fjocI
0
0
0
@rpharms
Royal Pharmaceutical Society
1 month
New to the e-library: The Movement Disorders Prescriber’s Guide to Parkinson’s Disease (2025) Find it here: https://t.co/QReEtAvXI3 under ‘Nervous System’, ‘Movement Disorders’ #RPSLibrary
1
1
0
@mimsonline
MIMS Online
1 month
Antidepressants differ significantly in their effects on body mass and other cardiometabolic measures, a review has found. Read more on MIMS:
0
1
1
@ptsafetylearn
Patient Safety Learning
1 month
Report added to the hub - A framework for the safe, efficient and effective implementation, use and maintenance of AI in health and care in London.
Tweet card summary image
pslhub.org
This document provides an overview of the agreed way of implementing and monitoring Artificial Intelligence (AI) products in the London health and care system. 
0
1
0
@RaziaAliani
Razia Aliani
1 month
The question every educator is asking: "Did my student actually write this?" The solution is NOT ⤵️ — better detection software. — going back to handwritten exams. — pretending AI doesn't exist. Here's what I learned from reading this book ⤵️ 𝗜𝗻𝘀𝘁𝗲𝗮𝗱 𝗼𝗳
6
78
281
@ChemistDruggist
Chemist+Druggist
1 month
Pharmacist warned for approving scripts via ‘thumbs up emoji’ https://t.co/H4QMkUUJHv The General Pharmaceutical Council (GPhC) has warned a pharmacist who used WhatsApp to “remotely” check and approve prescriptions @TheGPhC
Tweet card summary image
chemistanddruggist.co.uk
The General Pharmaceutical Council (GPhC) has warned a pharmacist who used WhatsApp to “remotely” check and approve prescriptions.
1
1
2
@Drug_Evidence
Therapeutics Initiative
1 month
ICYMI: TI Therapeutics Letter 157: How to🛑antidepressants 👉 https://t.co/i0YXOaW0Fo 🐌 Avoid abrupt discontinuation 🖥️ Monitor patients after dose reduction 👩🏽‍🏫 Patient education + shared decision-making to minimize harms, improve outcomes #deprescribing #MedEd #antidepressants
0
6
6
@PrescQIPP
PrescQIPP CIC
1 month
📣Join our PROMPPT webinar for expert insight into reducing opioid use for patients suffering persistent pain. 🧑‍⚕️You'll learn how the PROMPPT toolkit supports personalised reviews - and find out about the associated pharmacist training package. Our guest speakers will:
0
2
1
@jensmithmi
Jen Smith
1 month
Data protection involves being mindful of everyday interactions and habits. It's about being aware, not just about following 'procedures'.
@ptsafetylearn
Patient Safety Learning
1 month
Data privacy concerns that go far beyond the seemingly harmless waiting room - a new blog featured on the hub today. https://t.co/RwLQ2Skf0G #patientsafety
0
0
1
@jensmithmi
Jen Smith
1 month
So, when you're querying #AI, be careful about 'leading questions'. "What do you think of..." may be better than "Do you agree that...?"
@ptsafetylearn
Patient Safety Learning
1 month
Article added to the hub - When helpfulness backfires: LLMs and the risk of false medical information due to sycophantic behavior. https://t.co/4YMxCoRdmz #patientsafety
0
0
0
@KMonkemuller
Klaus Mönkemüller, MD, PhD
1 month
🤖 Potential dangers of AI in Medicine - De-Skilling - Mis-Skilling - Never-Skilling Nice editorial: https://t.co/xDK19Yux4R
3
44
162
@jensmithmi
Jen Smith
1 month
How good is #AI? The worst it's ever going to be. ChatGPT-5 hallucinates less than 4o. So if you're looking at research on using AI, the really old stuff (like six months ago!) may not reflect current capability. See
Tweet card summary image
openai.com
Our smartest, fastest, most useful model yet, with built-in thinking that puts expert-level intelligence in everyone’s hands.
0
0
1
@docmilanfar
Peyman Milanfar
1 month
You should be so lucky to have people throughout your research career that you can openly bounce ideas to and from - especially if they complement your strengths in your areas of weakness - it is a rare and precious gift.
28
269
2K